The EC authorizes certain uses of 4-tert-OPnEO and 4-NPnEO
On June 13, 2023, the European Commission (EC) published in the Official Journal of the European Union (EU) several authorization decisions concerning uses of 4-tert-OPnEO and 4-NPnEO, Substances of Very High Concern (SVHC). The authorizations concern QIAGEN, STAT-Dx Life and QIAGEN Distribution.